These findings not only corroborate the importance of the PDGFA-PDGFRA-CREB1-PLAT signaling axis in glioma progression but also demonstrate the efficacy of our network-based approach in pinpointing critical molecular determinants of disease states. This evidence concerns the gene PDGFRA and central nervous system cancer.